{
  "buildId": "5lGULuFSFhUrfWgBpMJq_",
  "gssp": true,
  "isFallback": false,
  "page": "/calc/[...slug]",
  "props": {
    "__N_SSP": true,
    "pageProps": {
      "calc": {
        "before_use": "",
        "calc_type": "",
        "chief_complaint_en": [
          "Abdominal Pain",
          "Dysuria",
          "Hematuria",
          "Pain"
        ],
        "cmeEndDate": null,
        "cmeLastReviewed": null,
        "cmeReleaseDate": null,
        "cme_status": "",
        "content": {
          "about": {
            "evidence_based_medicine_en": "<p>Guidelines for IRAE in for renal&nbsp; toxicity (nephritis) were developed by a multidisciplinary, multi-organizational panel of experts in medical oncology based on a systematic review of the medical literature.</p>",
            "formula_en": "<div dir=\"ltr\" align=\"left\">\n<table><colgroup><col width=\"258\" /><col width=\"190\" /><col /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Criteria</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Nephritis grade</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Creatinine level increase of &gt;0.3 mg/dL; creatinine 1.5-2.0x over baseline</p>\n</td>\n<td>\n<p dir=\"ltr\">G1</p>\n</td>\n<td>\n<p dir=\"ltr\"></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Creatinine 2-3x above baseline</p>\n</td>\n<td>\n<p dir=\"ltr\">G2</p>\n</td>\n<td>\n<p dir=\"ltr\"></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Creatinine &gt;3x baseline or &gt;4.0 mg/dL; hospitalization indicated</p>\n</td>\n<td>\n<p dir=\"ltr\">G3</p>\n</td>\n<td>\n<p dir=\"ltr\"></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Life-threatening consequences; dialysis indicated</p>\n</td>\n<td>\n<p dir=\"ltr\">G4</p>\n</td>\n<td>\n<p dir=\"ltr\"></p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p></p>\n<p dir=\"ltr\">See Next Steps for details on management.</p>",
            "more_info_en": "",
            "references_list": {
              "Clinical Practice Guidelines": [],
              "Manufacturer Website": [],
              "Original/Primary Reference": [
                {
                  "href": "ttps://www.ncbi.nlm.nih.gov/pubmed/29442540",
                  "text": "Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-1768."
                }
              ],
              "Other References": [],
              "Outcomes": [],
              "Validation": []
            }
          },
          "contributor": {
            "expert_name": [
              "Nazli Dizman, MD"
            ]
          },
          "creator": [
            {
              "approved": false,
              "name": "Dr. Julie R. Brahmer",
              "qa_en": ""
            }
          ],
          "how_to_use": {
            "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-a8ce4840-7fff-77be-9fe6-3bba96803f0a\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Immune checkpoint inhibitor (ICPi) nephritis should be suspected in patients with elevations in creatinine levels or symptoms suggesting nephritis while on treatment with immune checkpoint inhibitors.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Immune checkpoint inhibitor (ICPi) nephritis is an uncommon but potentially serious toxicity.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">More frequently seen with combination treatment of more than one ICPi but is also an important adverse event caused by single agent ICPi.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">ICPi therapy appears to be safe in patients with baseline renal impairment from nonimmune basis (i.e. prior nephrectomy, old age, hypertension).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Management of ICPi nephritis is based on the grade of nephritis.</p>\n</li>\n</ul>",
            "use_case_en": "<p>Adult patients with elevations in creatinine levels or symptoms suggesting nephritis that developed while on treatment with immune checkpoint inhibitors including agents against PD-1 (i.e. pembrolizumab, nivolumab), PD-L1 (i.e. atezolizumab, avelumab, durvalumab), or CTLA-4 (i.e. ipilimumab).</p>",
            "why_use_en": "<p><span id=\"docs-internal-guid-5ce2b588-7fff-2210-e053-3e4e73c9e75e\">This tool aids in the decision of immune checkpoint inhibitor discontinuation, further diagnostic work-up and immunosuppressant treatment initiation.</p>"
          },
          "next_steps": {
            "advice_en": "<p>Monitor patients for elevated serum creatinine prior to every dose.&nbsp;</p>\n<p>For suspected ICPi nephritis, consider holding therapy while other potential causes are evaluated (i.e. recent IV radiographic contrast administration, dehydration, other medicines, urinary tract infections) and monitor creatinine weekly.</p>\n<p>Routine urinalysis is not necessary other than to rule out urinary tract infections, etc.</p>\n<p>Presume ICPi nephritis for patients without other obvious causes or for those who do not respond to alternative treatment measures.</p>\n<p>If no potential alternative cause of acute kidney injury (AKI) is identified, then consider biopsy and proceed directly with immunosuppressive therapy.</p>",
            "critical_actions_en": "",
            "management_en": "<p dir=\"ltr\">For all patients where an IRAE diagnosis is being considered, it is always recommended to involve the specialist or team prescribing the immune checkpoint therapy.&nbsp;</p>\n<p dir=\"ltr\"><strong>All patients:</strong></p>\n<p dir=\"ltr\">Monitor creatinine weekly.</p>\n<p dir=\"ltr\">Kidney biopsy should be discouraged until corticosteroid treatment has been attempted.</p>\n<p dir=\"ltr\"><strong>Grade 1:&nbsp;</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider temporarily holding ICPi, pending consideration of potential alternative etiologies (recent IV contrast, medications, fluid status) and baseline renal function.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">A change that is still &lt;1.5 ULN could be meaningful.</p>\n</li>\n</ul>\n<p dir=\"ltr\"><strong>Grade 2:</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Hold treatment temporarily.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider nephrology consultation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Evaluate for other causes (recent IV contrast, medications, fluid status, etc). If other etiologies are ruled out, administer 0.5-1 mg/kg/d prednisone equivalents.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If worsening or no improvement, consider 1-2 mg/kg/d prednisone or equivalent and permanently discontinue ICPi.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If improved to &le; Grade 1, taper corticosteroids over 4-6 weeks.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If no recurrence of chronic renal insufficiency, discuss resumption of ICPi with patient after thorough discussion of risks and benefits.</p>\n</li>\n</ul>\n<p dir=\"ltr\"><strong>Grade 3-4:</strong></p>\n<p><span id=\"docs-internal-guid-0a217669-7fff-bbce-ab85-760154b2b031\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Permanently discontinue ICPi.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider Consult nephrology consultation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Evaluate for other causes (recent IV contrast, medications, fluid status, etc).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider corticosteroids (initial dose of 1-2 mg/kg/d prednisone or equivalent).</p>\n</li>\n</ul>"
          },
          "related_resources": {
            "guidelines": [],
            "interests": [],
            "mdcalc_rating": [],
            "partner_contact": [],
            "sdm_tool": [],
            "teaching": [],
            "videos": []
          },
          "reviewer": []
        },
        "disease_en": [
          "Nephritis"
        ],
        "dosing": false,
        "equation_logic_text": "var calc_output = [];\n\nvar grading = parseFloat(grading);\nvar rec;\n\nswitch (grading) {\n  case 1:\n    rec = 'Consider temporarily holding ICPi, pending consideration of alternative etiologies and baseline renal function; monitor creatinine weekly; see Next Steps for details';\n    break;\n  case 2:\n    rec = 'Hold ICPi temporarily; consult nephrology; evaluate for other causes; if other etiologies are ruled out, administer 0.5-1 mg/kg/d prednisone; monitor creatinine weekly; If worsening or no improvement, administer 1-2 mg/kg/d prednisone and permanently discontinue ICPi; If improved to â‰¤ Grade 1, taper steroids and may consider resumption after thorough discussion of risks; see Next Steps for details';\n    break;\n  case 3:\n    rec = 'Permanently discontinue ICPi; consult nephrology; evaluate for other causes; monitor creatinine weekly; administer steroids with initial dose of 1-2 mg/kg/d; see Next Steps for details';\n    break;\n  case 4:\n    rec = 'Permanently discontinue ICPi; consult nephrology; evaluate for other causes; monitor creatinine weekly; administer steroids with initial dose of 1-2 mg/kg/d; see Next Steps for details';\n}\n\n//results\ncalc_output.push({\n    name: 'mini',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Nephritis grade'   \n});\ncalc_output.push({\n    name: 'Score',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Nephritis grade'   \n});\ncalc_output.push({\n    name: 'risk1',\n    value: '', \n    value_text: '',\n    message: rec\n});\n",
        "favorite_id": 10378,
        "full_title_en": "Immune-Related Adverse Events for Renal Toxicities - Nephritis",
        "input_schema": [
          {
            "conditionality": "",
            "default": null,
            "label_en": "Criteria",
            "name": "grading",
            "optional": false,
            "options": [
              {
                "label": "Creatinine level increase of >0.3 mg/dL; creatinine 1.5-2.0x over baseline",
                "value": 1
              },
              {
                "label": "Creatinine 2-3x above baseline",
                "value": 2
              },
              {
                "label": "Creatinine >3x baseline or >4.0 mg/dL; hospitalization indicated",
                "value": 3
              },
              {
                "label": "Life-threatening consequences; dialysis indicated",
                "value": 4
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "radio"
          }
        ],
        "instructions_en": "<p>Use in adult patients with elevations in creatinine levels or symptoms suggesting nephritis while on treatment with immune checkpoint inhibitors.</p>",
        "md5": "",
        "medium_description_en": "<p>Grades severity of nephritis secondary to immune checkpoint inhibitor therapy.</p>",
        "purpose_en": [
          "Diagnosis",
          "Prognosis"
        ],
        "search_abbreviation_en": [
          "Immune Related Adverse Events, irae, nephritis, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO"
        ],
        "search_id": "c-10378",
        "seo": {
          "keywords_en": "Immune Related Adverse Events, irae, nephritis, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO",
          "meta_description_en": "The Immune-Related Adverse Events for Renal Toxicities - Nephritis grades severity of nephritis secondary to immune checkpoint inhibitor therapy."
        },
        "short_description_en": "Nephritis severity (ICPi therapy).",
        "short_title_en": "IRAE for Renal Toxicities - Nephritis",
        "slug": "immune-related-adverse-events-renal-toxicities-nephritis",
        "specialty_en": [
          "Allergy and Immunology",
          "Hospitalist Medicine",
          "Internal Medicine",
          "Nephrology"
        ],
        "system_en": [
          "Renal"
        ]
      },
      "contributors": [
        {
          "contributors_page": false,
          "description": "",
          "firstName": "Nazli",
          "hasDisclosure": [],
          "img": "",
          "lastName": "Dizman",
          "name": "Nazli Dizman, MD",
          "signedCOI": true,
          "status": "",
          "target": ""
        }
      ],
      "creators": [
        {
          "about_en": "<p>Julie R. Brahmer, MSc, MD, is the co-director of the upper aerodigestive department at Johns Hopkins Medicine in Baltimore, MD. She is also a professor of oncology at Johns Hopkins Medicine. Dr. Brahmerâ€™s primary research is focused on treatment of lung cancer and mesothelioma.</p>",
          "deceased": false,
          "description": "",
          "firstName": "",
          "img": "",
          "lastName": "",
          "name": "Dr. Julie R. Brahmer",
          "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-julie-brahmer.png",
          "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Brahmer+JR%5BAuthor%5D",
          "signedCOI": false
        }
      ],
      "envs": {
        "CANONICAL_URL_ROOT": "https://www.mdcalc.com",
        "CONTENT_SERVER_TAG": "WEB_PROD",
        "RECAPTCHA_PUBLIC_KEY": "6Lcu1mMkAAAAAAwmSDO3I7JNaUo9YtZ3jnrzTP6a",
        "STRIPE_PUB_KEY": "pk_live_yYm2UzDzaudhFgqWcKbv9vH7"
      },
      "faqs": [
        {
          "cme_faq": {
            "answer": "<p>MDCalc&rsquo;s Continuing Medical Education (CME) service allows users to easily earn AMA PRA Category 1 CreditsTM through regular use of MDCalc. Simply put, on top of getting the best medical calculators in the world, your usage will help you achieve your annual CME requirements, including specialty CME, without any extra effort.</p>",
            "question": "What is MDCalc CME?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Yes, in support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MDCalc Ltd. Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p>",
            "question": "Is MDCalc CME accredited?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Only United States attending physicians, nurse practitioners, nurses, and physician assistants are eligible for our CME service.</p>",
            "question": "Who can enroll and how?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>We have over 275 CME-eligible calculators across various specialties. You can read the clinical content supporting any CME calculators to start earning. Once you have viewed all the supporting content for a calculator, you will have officially earned the credit amount (0.5 credits) and will be able to redeem a certificate. For now, only calc content in CME-eligible calcs is eligible for CME credits, however, we&rsquo;ll be expanding our CME service to include more of our content in the future.</p>",
            "question": "What activities can I do to earn CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Simply use our search bar or visit our homepage to easily find CME-eligible calcs. You must be enrolled in our CME service to see which calcs are CME-eligible.</p>",
            "question": "Where can I find calcs with which I can earn credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Once you&rsquo;ve enrolled in our CME service, you will have a personal CME Dashboard where you can view all of your earned credits. You can navigate to the dashboard by clicking the CME button in the header at the top of any page.</p>",
            "question": "Where can I see which credits Iâ€™ve earned?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Go to your CME Dashboard and select the credits you&rsquo;d like to redeem, fill out a few dropdown answers about how you used the calc, and then proceed to checkout.</p>",
            "question": "How do I redeem CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>No. Earning credits as you use calcs is free, but either you (or your employer) will need to purchase an annual subscription to redeem your CME certificates.</p>",
            "question": "Are CME credits free?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Just like with earned credits, you can view your CME certificates on your CME Dashboard in the &ldquo;CME Certificates&rdquo; tab. Certificates include a list of all of the calcs for which CME was earned along with a tally of the specialty CME.</p>",
            "question": "Where can I see my CME certificates?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>One year from the date of purchase.</p>",
            "question": "How long do credits in an annual subscription last?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>General; Addiction and Controlled Substances; Cardiac Care; Domestic and Intimate Partner Violence; Geriatrics; HIV and Infectious Disease; Hospice, End-of-Life, Terminal Illness, and Palliative Care; Mental and Behavioral Health; Pain Management; Pediatrics; Stroke; and Trauma.</p>",
            "question": "What specialty CME credits are included in the plan?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Your gift card will be sent via email within 1-2 business days of making your purchase. You will be able to select from the following options - Visa, Amazon.com, Apple. Be sure to claim your gift card offer within 90 days of receiving the email.</p>\n<p>Your CME purchase may have implications for tax reporting purposes. The cost of your CME product may or may not be tax-deductible when used for professional purposes. Any reimbursed amount for incentives must be declared as personal income for tax purposes. Please consult your tax advisor. MDCalc does not provide tax advice.</p>",
            "question": "I ordered a CME package with a gift card. How does it work?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Per the new guidelines from ACCME, the receipt will separate the cost you paid into the cost of the gift card and the cost of the CME learning activity.</p>",
            "question": "What will show on my receipt for CME when it includes a gift card?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can get a refund (minus any promotional gift amount) within 30-days if the ease of earning and redeeming does not meet your expectations and if you have redeemed no more than 4 credits. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request a refund.</p>",
            "question": "How do I get a refund if I'm not satisfied?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can upgrade your subscription throughout your billing cycle and pay the difference for a higher plan. You may request to downgrade your plan to a lower level to coincide with your next renewal. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request changes.</p>",
            "question": "How do I later upgrade to a different plan if I need more credits?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Gift card plans are available for 1 year and do not auto-renew. Standard, non gift-card subscriptions are auto-renewed annually. You can disable the automatic renewal of your subscription at any time by emailing <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a>.</p>",
            "question": "Do CME plans auto-renew?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>If you&rsquo;re part of a team or practice that wants to sign up five or more physicians, please email us at <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> for more information.</p>",
            "question": "How do I get information on a discounted bulk subscription program for my institution, team, or practice?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>On July 28, 2022, ACCME updated the guidelines regarding the use of high-value incentives. These guidelines allow for the use of gift card rewards in a regulated manner. Visit the ACCME website to read their guidelines.</p>",
            "question": "Did the ACCME decide to regulate gift cards?",
            "type": "Purchasing"
          }
        }
      ],
      "headConfig": {
        "canonicalUrl": "/calc/10378/immune-related-adverse-events-renal-toxicities-nephritis",
        "description": "The Immune-Related Adverse Events for Renal Toxicities - Nephritis grades severity of nephritis secondary to immune checkpoint inhibitor therapy.",
        "keywords": "Immune Related Adverse Events, irae, nephritis, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO",
        "title": "Immune-Related Adverse Events for Renal Toxicities - Nephritis"
      },
      "isCMECalc": false,
      "measurements": [],
      "relCalcs": [
        {
          "calcId": 10389,
          "short_title_en": "IRAE for GI Toxicity - Hepatitis",
          "slug": "immune-related-adverse-events-gi-toxicity-hepatitis"
        },
        {
          "calcId": 10382,
          "short_title_en": "IRAE for Endocrine Toxicities - Hypothyroidism",
          "slug": "immune-related-adverse-events-endocrine-toxicities-hypothyroidism"
        },
        {
          "calcId": 10383,
          "short_title_en": "IRAE for Lung Toxicity - Pneumonitis",
          "slug": "immune-related-adverse-events-lung-toxicity-pneumonitis"
        }
      ],
      "societies": {
        "American Association for the Study of Liver Diseases": {
          "abbreviation": "AASLD",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.aasld.org/"
        },
        "American College Of Emergency Physicians": {
          "abbreviation": "ACEP",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/american-college-of-emergency-physicians-squarelogo.png",
          "web_link": "https://www.acep.org/"
        },
        "American College of Gastroenterology": {
          "abbreviation": "ACG",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/acg_logo.png",
          "web_link": "https://gi.org/"
        },
        "American College of Rheumatology": {
          "abbreviation": "ACR",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.rheumatology.org/"
        },
        "American Gastroenterological Association": {
          "abbreviation": "AGA",
          "description": "plain-text",
          "img": "https://apps.mdcalc.com/images/societies/aga.jpeg",
          "web_link": "https://gastro.org"
        },
        "American Heart Association": {
          "abbreviation": "AHA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/societies/+AHA+(American+Heart+Association).png",
          "target": "aha",
          "web_link": "http://www.heart.org/HEARTORG/"
        },
        "American Urological Association": {
          "abbreviation": "AUA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.auanet.org/"
        },
        "EB Medicine": {
          "abbreviation": "EB Medicine",
          "description": "EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.",
          "img": "https://cdn-web-img.mdcalc.com/other/eb_medicine-icon-only.jpg",
          "target": "eb-medicine",
          "web_link": "http://www.ebmedicine.net/"
        },
        "MDCalc CME": {
          "abbreviation": "MDCalc CME",
          "img": "https://cdn-web-img.mdcalc.com/Stroke-CME-content.jpg",
          "web_link": "https://www.mdcalc.com/stroke-cme?utm_source=NIHSS_calc&utm_medium=NIHSS_calc&utm_campaign=NIHSS_calc"
        },
        "OTHER": {
          "abbreviation": "OTHER"
        },
        "Postgraduate Institute for Medicine": {
          "abbreviation": "PIM",
          "description": "plain-text",
          "img": "https://cdn-web-img.mdcalc.com/PIM-circle-COLOR.jpeg",
          "target": "pim",
          "web_link": "https://www.pimed.com/"
        },
        "VACO Podcast": {
          "description": "Listen to the VACO co-creators break down how to use VACO\\, what it does\\, and what it doesnâ€™t.",
          "img": "https://cdn-web-img.mdcalc.com/content/podcast 2.png",
          "web_link": "https://www.stimuluspodcast.com/post/32-the-covid-mortality-score-vaco"
        }
      },
      "validSections": [
        "whenToUseViewed",
        "pearlsPitfallsViewed",
        "whyUseViewed",
        "nextStepsViewed",
        "evidenceViewed"
      ]
    }
  },
  "query": {
    "slug": [
      "10378",
      "immune-related-adverse-events-renal-toxicities-nephritis"
    ]
  },
  "scriptLoader": []
}